Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armin Schultz

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Pharmacology & Physiology|September 3, 2011
Dalteparin dose-dependently increases ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro studyMartin Feuring, Martin Wehling, Armin Schultz
Steroids|January 20, 2007
To be or not to be (a receptor)Martin Wehling, Armin Schultz, Ralf Lösel
Molecular and Cellular Endocrinology|May 12, 2004
A quick glance at rapid aldosterone actionRalf Lösel, Armin Schultz, Martin Wehling
Maturitas|May 30, 2006
Nongenomic actions of estrogens: exciting opportunities for pharmacologyMartin Wehling, Armin Schultz, Ralf Lösel
Seminars in Thrombosis and Hemostasis|September 9, 2005
Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100Martin Feuring, Armin Schultz, Ralf Losel, et al.
Steroids|August 4, 2004
Rapid effects of aldosterone on vascular cells: clinical implicationsRalf Lösel, Armin Schultz, Brigitte Boldyreff, et al.
Springerplus|August 9, 2014
Effects of combined netupitant and palonosetron (NEPA), a cancer supportive care antiemetic, on the ECG of healthy subjects: an ICH E14 thorough QT trialTulla Spinelli, Cecilia Moresino, Sybille Baumann, et al.
Current Opinion in Allergy and Clinical Immunology|February 13, 2003
Novel approaches in the treatment of allergic rhinitisArmin Schultz, Boris Alexander Stuck, Martin Feuring, et al.
Basic & Clinical Pharmacology & Toxicology|February 11, 2018
Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open-Label, Fixed-Sequence, Crossover StudyFenglei Huang, Claudia Voelk, Matthias Trampisch, et al.
Diabetes, Obesity & Metabolism|October 7, 2024
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low-dose liraglutide in otherwise healthy men with overweight or obesityNadine Beetz, Brigitte Kalsch, Thomas Forst, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Pharmacology & Physiology|September 3, 2011
Dalteparin dose-dependently increases ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro studyMartin Feuring, Martin Wehling, Armin Schultz
Steroids|January 20, 2007
To be or not to be (a receptor)Martin Wehling, Armin Schultz, Ralf Lösel
Molecular and Cellular Endocrinology|May 12, 2004
A quick glance at rapid aldosterone actionRalf Lösel, Armin Schultz, Martin Wehling
Maturitas|May 30, 2006
Nongenomic actions of estrogens: exciting opportunities for pharmacologyMartin Wehling, Armin Schultz, Ralf Lösel
Seminars in Thrombosis and Hemostasis|September 9, 2005
Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100Martin Feuring, Armin Schultz, Ralf Losel, et al.
Steroids|August 4, 2004
Rapid effects of aldosterone on vascular cells: clinical implicationsRalf Lösel, Armin Schultz, Brigitte Boldyreff, et al.
Springerplus|August 9, 2014
Effects of combined netupitant and palonosetron (NEPA), a cancer supportive care antiemetic, on the ECG of healthy subjects: an ICH E14 thorough QT trialTulla Spinelli, Cecilia Moresino, Sybille Baumann, et al.
Current Opinion in Allergy and Clinical Immunology|February 13, 2003
Novel approaches in the treatment of allergic rhinitisArmin Schultz, Boris Alexander Stuck, Martin Feuring, et al.
Basic & Clinical Pharmacology & Toxicology|February 11, 2018
Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open-Label, Fixed-Sequence, Crossover StudyFenglei Huang, Claudia Voelk, Matthias Trampisch, et al.
Diabetes, Obesity & Metabolism|October 7, 2024
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low-dose liraglutide in otherwise healthy men with overweight or obesityNadine Beetz, Brigitte Kalsch, Thomas Forst, et al.
Pageof 3